Despite recent advances in immunotherapy and targeted therapy, most patients with non-small-cell lung cancer (NSCLC) continue to have disease progression and develop resistance to current treatments.

Rare medical events draw intense attention during any mass vaccination campaign. Among COVID vaccine side effects, few stories triggered more concern than unusual clotting after certain shots. Doctors ...

FDA panel backs fall Covid shot update to target the XFG variant, enabling manufacturers to reformulate vaccines for the upcoming surge season.

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...

The advisory panel recommended updating this fall’s Covid shots to target the XFG variant, a fast-growing strain nicknamed “stratus.” ...

HIV patients can be drug-free for up to two years under a treatment that ends the need for daily pills. A new antibody ...

A Mount Sinai-led research team has demonstrated that autoimmunity, in which the body's immune system attacks its own tissues ...

Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up ...

Ebola virus symptoms, transmission, treatment, and why there is currently no immediate risk in India despite recent outbreaks reported in Central Africa.

SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, compares ...

Andes hantavirus causes deadly lung failure, but its method of attack differs from other respiratory illnesses. The details ...

The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a ...